Elife
| WoS 期刊 JCR 分区 (2026 · JIF) | 综合 SCIE | Q1 | ||
|---|---|---|---|---|
| 学科 | 收录集 | JIF 分区 | JIF 排名 | JIF 百分位 |
| 生物学 Biology | ESCI | N/A | — |
—
|
| 学科 | 收录集 | JCI 分区 | JCI 排名 | JCI 百分位 |
|---|---|---|---|---|
| 生物学 Biology | ESCI | Q1 | 6/95 JCI 1.88 |
94.7%
|
eLife is a premier open-access journal that has rapidly established itself as a leading venue for high-impact research across the life sciences and biomedicine. Published by eLife Sciences Publications, Ltd., a nonprofit organization, the journal operates under a unique model that emphasizes rigorous, constructive peer review and the swift dissemination of significant findings. Its scope is broad, encompassing all areas of biology and medicine, from molecular and cellular biology to neuroscience, genetics, ecology, and evolutionary biology. The journal primarily publishes original Research Articles, which undergo a transparent and collaborative review process. In addition to these, eLife features Short Reports for concise findings, Research Advances that build on previously published work, and Review Articles that synthesize current knowledge in key areas. The target audience includes academic researchers, clinicians, and graduate students who seek access to pioneering, reproducible, and ethically sound science. A defining feature of eLife is its fully open-access policy, ensuring that all content is freely available to readers worldwide. The journal is also notable for its data-sharing requirements and its commitment to eliminating the stigma associated with negative or null results, encouraging submissions that advance scientific understanding regardless of outcome. With a Journal Citation Reports (JCR) Quartile of Q1 and a consistently high impact factor, eLife is widely regarded as one of the top-tier journals in the life sciences, competing with other elite publications while championing a more equitable and transparent publishing culture.